{"id":12780,"date":"2024-10-11T15:57:29","date_gmt":"2024-10-11T13:57:29","guid":{"rendered":"https:\/\/valintermed.com\/?p=12780"},"modified":"2024-10-11T15:57:29","modified_gmt":"2024-10-11T13:57:29","slug":"rabdomiosarkoma-embrionalnaya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/embryonic-rabdomyosarcoma\/","title":{"rendered":"Embryonic rhabdomyosarcoma"},"content":{"rendered":"
<\/div>\n

Embryonic rhabdomyosarcoma is a rare but highly aggressive tumor type originating from undifferentiated myoblasts, the sites from which skeletal muscle develops. The disease begins in early childhood, predominantly in children under 5 years of age, and can affect various anatomical sites, including the head, neck, spine, and abdominal and pelvic organs. The main pathological feature is the presence of rhabdomyoblasts, which are visualized during histological examination. These tumors have significant heterogeneity, and their clinical presentation may vary depending on age and site of localization. Treatment of rhabdomyosarcoma involves a multidisciplinary approach and combined methods aimed at achieving maximum remission.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n